InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,477.90
(
0.16%
)
US TECH 100
19,129.60
(
-0.24%
)
Dow Jones
39,127.80
(
0.04%
)
Brent Oil
84.22
(
-0.30%
)
Bitcoin
61,019.28
(
0.34%
)
Post# of 188583
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Traderzz

Send PM Follow Ignore
Followers 57
Posts 19762
Boards Moderated 1
Alias Born 02/16/2008

Traderzz

Re: Traderzz post# 175868

Wednesday, 12/09/2009 11:40:44 AM

Wednesday, December 09, 2009 11:40:44 AM

Post# of 188583
Vanda Pharmaceuticals Inc. (VNDA:US) rose 5.1 percent to $11.63 and gained 7.4 percent earlier, the most intraday since Oct. 13. The Rockville, Maryland-based drugmaker was rated new “buy” at Jefferies Group Inc., which cited the sale of Vanda’s U.S. and Canadian rights for its schizophrenia drug Fanapt to Novartis AG (NVS:US).

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up